This topic contains a solution. Click here to go to the answer

Author Question: Which statement is true about loss of bone strength in middle adulthood? A) Loss in bone density ... (Read 86 times)

cmoore54

  • Hero Member
  • *****
  • Posts: 568
Which statement is true about loss of bone strength in middle adulthood?
 
  A) Loss in bone density usually begins in the early twenties and accelerates in the thirties.
  B) Environmental factors do little to slow bone loss in postmenopausal women.
  C) Loss of bone strength causes the disks of the spinal column to collapse.
  D) By the end of middle adulthood, women have lost 70 percent of their bone density.

Question 2

Which statement is true about the aging skeleton?
 
  A) Bones become more porous with age.
  B) Bones narrow with age, as new cells accumulate.
  C) With age, the mineral content of bones increases.
  D) Mens reserve of bone minerals is lower than womens.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

brittrenee

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Answer: C

Answer to Question 2

Answer: A




cmoore54

  • Member
  • Posts: 568
Reply 2 on: Jun 22, 2018
Wow, this really help


shewald78

  • Member
  • Posts: 340
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library